BIOMAT Database Logo BIOMAT Database Logo

Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus. 2016

Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
1 Osel, Inc. , Mountain View, California.

Eradication of human immunodeficiency virus type 1 (HIV-1) by vaccination with epitopes that produce broadly neutralizing antibodies is the ultimate goal for HIV prevention. However, generating appropriate immune responses has proven difficult. Expression of broadly neutralizing antibodies by vaginal colonizing lactobacilli provides an approach to passively target these antibodies to the mucosa. We tested the feasibility of expressing single-chain and single-domain antibodies (dAbs) in Lactobacillus to be used as a topical microbicide/live biotherapeutic. Lactobacilli provide an excellent platform to express anti-HIV proteins. Broadly neutralizing antibodies have been identified against epitopes on the HIV-1 envelope and have been made into active antibody fragments. We tested single-chain variable fragment m9 and dAb-m36 and its derivative m36.4 as prototype antibodies. We cloned and expressed the antibody fragments m9, m36, and m36.4 in Lactobacillus jensenii-1153 and tested the expression levels and functionality. We made a recombinant L. jensenii 1153-1128 that expresses dAb-m36.4. All antibody fragments m9, m36, and m36.4 were expressed by lactobacilli. However, we noted the smaller m36/m36.4 were expressed to higher levels, ≥3 μg/ml. All L. jensenii-expressed antibody fragments bound to gp120/CD4 complex; Lactobacillus-produced m36.4 inhibited HIV-1BaL in a neutralization assay. Using a TZM-bl assay, we characterized the breadth of neutralization of the m36.4. Delivery of dAbs by Lactobacillus could provide passive transfer of these antibodies to the mucosa and longevity at the site of HIV-1 transmission.

UI MeSH Term Description Entries
D007778 Lactobacillus A genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Lactobacillus species are homofermentative and ferment a broad spectrum of carbohydrates often host-adapted but do not ferment PENTOSES. Most members were previously assigned to the Lactobacillus delbrueckii group. Pathogenicity from this genus is rare.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014621 Vagina The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed) Vaginas
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D057134 Antibodies, Neutralizing Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus. Neutralizing Antibodies,Antibody, Neutralizing,Neutralizing Antibody

Related Publications

Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.
December 1994, AIDS research and human retroviruses,
Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay.
September 1996, AIDS research and human retroviruses,
Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.
December 2008, Journal of virology,
Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.
December 2008, Journal of virology,
Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.
June 2007, Journal of virology,
Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype.
June 1995, The Journal of pediatrics,
Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.
June 2007, Journal of virology,
Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody.
April 2006, FEBS letters,
Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.
August 2015, Journal of virology,
Angela Marcobal, and Xiaowen Liu, and Wenlei Zhang, and Antony S Dimitrov, and Letong Jia, and Peter P Lee, and Timothy R Fouts, and Thomas P Parks, and Laurel A Lagenaur
Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
May 2005, Journal of virology,
Copied contents to your clipboard!